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Abstract
Objective: Toll like receptors (TLRs) are one of the main components of the innate im-
mune system. It has been reported that expression of these receptors are altered in the 
female reproductive tract (FRT) during menstrual cycle. Here we used a fallopian tube 
epithelial cell line (OE-E6/E7) to evaluate the effect of two sex hormones in modulating 
TLR expression. 
Materials and Methods: In this experimental study, initially TLR gene expression in OE-
E6/E7 cells was evaluated and compared with that of fallopian tube tissue using quanti-
tative real time-polymerase chain reaction (qRT-PCR) and immunostaining. Thereafter, 
OE-E6/E7 cells were cultured with different concentrations of estradiol and progesterone, 
and combination of both. qRT-PCR was performed to reveal any changes in expression of 
TLR genes as a result of hormonal treatment.    
Results: TLR1-10 genes were expressed in human fallopian tube tissue. TLR1-6 genes 
and their respective proteins were expressed in the OE-E6/E7 cell line. Although estradiol 
and progesterone separately had no significant effect on TLR expression, their combined 
treatment altered the expression of TLRs in this cell line. Also, the pattern of TLR expres-
sion in preovulation (P), mensturation (M) and window of implantation (W) were the same 
for all TLRs with no significant differences between P, M and W groups.                    
Conclusion: These data show the significant involvement of the combination of es-
tradiol and progesterone in modulation of TLR gene expression in this human fal-
lopian tube cell line. Further experiments may reveal the regulatory mechanism and 
signalling pathway behind the effect of sex hormones in modulating TLRs in the hu-
man FRT.         
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Introduction
Infection within the upper regions of the female 
reproductive tract (FRT), particularly the fallopi-
an tubes, can have serious consequences such as 
chronic pelvic inflammation, infertility and preg-
nancy complications (1, 2). For example, sexually 
transmitted diseases (STDs) that infect the upper 
regions of the FRT are a major worldwide health 
problem (3, 4). Approximately 8% of females 
annually develop pelvic inflammatory disease 
(PID) and after re-infection, this risk increases by 
40-70% (5) . It is thus of paramount importance 
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that infectious agents are quickly recognised and 
removed from the upper parts of the FRT. Char-
acterization of the defense systems present within 
the FRT will assist the development of effective 
therapies or vaccination strategies against STDs.
The innate immune system is the first line of de-
fense against infection. This system is able to iden-
tify what is foreign or non-self and produces ad-
equate responses that lead to the pathogens being 
suppressed. Toll like receptors (TLRs) are a fam-
ily of pattern recognition receptors that recognise 
pathogen-associated molecular patterns (PAMP) 
and constitute a major part of the innate immune 
system (6, 7). Until now, eleven members of this 
receptor family have been discovered in humans. 
Of these, TLR1–9 are conserved between human 
and mouse. Using various methods including ec-
topic expression of mammalian cDNA in cell 
lines, some of the activating ligands of TLRs have 
been discovered. Each individual TLR is known to 
detect molecules (ligands) from varying classes of 
microbial agents (8, 9). Some TLRs like TLR2 and 
its associated receptors TLR1 and TLR6 mainly 
react against Gram-positive bacteria by detecting 
molecules from mycobacteria and Gram-positive 
bacteria (10-12). Some PAMP, like lipoteichoic 
acid (LTA), can be detected only by TLR2 (11).
In contrast, TLR1 associates with TLR2 to rec-
ognize triacylated lipoproteins (13), whereas 
TLR2 together with TLR6 detects diacylated 
lipoproteins and peptidoglycans (14-16). TLR4 
recognises lipopolysaccharides (LPS) which 
are present in Gram-negative bacteria (17-19). 
TLR5 recognises bacterial flagellin (20). Other 
TLRs mainly react against viruses. For example, 
TLR3 recognises RNA from double stranded 
RNA viruses (21, 22). Also, TLR7 and 8 recog-
nise RNA from single stranded RNA viruses and 
antiviral compounds such as imidazoquinolines 
(16, 19, 23), whilst TLR9 recognises unmethyl-
ated CpG DNA found richly in prokaryotic ge-
nomes and DNA viruses (19, 24). Like TLR1 
and TLR6, TLR10 is another TLR2-associated 
receptor and also highly homologous to TLR2, 
however, the function of this TLR is not com-
pletely understood (25-27). In addition, it was 
revealed that the TLR pathway has physiologi-
cal relevance to human fertility TLR by playing 
roles in ovulation, sperm capacitation, fertili-
zation and pregnancy (28-31). They were also 
shown to play a role in the pathophysiology of 
relevant disorders including endometriosis and 
poor ovarian response (32, 33).
Several studies have investigated the pres-
ence and the role of TLRs in the male and FRTs 
(34-43). Furthermore, the expression of TLRs 
in endometrial cell lines have been shown by 
Abussahoud et al. (44). It is evident that sex 
hormones modulate cells and their immune re-
sponse potential, but varies throughout the FRT 
(45). Reports by us and others have demon-
strated the existence of TLRs in FRT and the 
cycle-dependent expression of TLRs in the en-
dometrium (34, 46). The effect of estradiol has 
also been showed in endometrial cells in several 
studies (47-49).
The cycle-dependent expression of TLRs in FRT 
implicates a role for sex hormones in regulation 
of TLR function in FRT. Here we used a fallopian 
tube epithelial cell line (OE-E6/E7) (50) to inves-
tigate the role of two sex hormones (estradiol and 
progesterone) in modulating TLR expression in 
the fallopian tube. This cell line has characteristics 
of human fallopian tube epithelial cells, including 
morphology, receptor expression and hormonal 
responses (50). Thereafter, the effect of the sex 
hormones and their combination as well as their 
antagonists on expression of TLR1-10 in fallopian 
tube cells was investigated. This was done by test-
ing TLR whether TLR expression is altered in the 
presence of sex hormones.
Materials and Methods
Fallopian tube tissue collection  
This investigation was an experimental study 
approved by the Royan Institute Ethics Com-
mittee.  Informed written consent was obtained 
prior to the collection of tissue samples. Hu-
man fallopian tube tissues were collected from 
9 patients undergoing total abdominal hyster-
ectomy for benign gynaecological conditions. 
The mean age of the women taking part in the 
study was 42 (range of 33-56) years with all in 
the secretory phase of their menstrual cycle. For 
genomic studies, fallopian tube tissue samples 
were immediately placed in RNAlater (Ambi-
on, UK) and stored for 24 hours at 4˚C followed 
by immersion and storage in liquid nitrogen un-
til the time of processing. 
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Antibodies and peptides
Antibodies and peptides used in the experi-
ments were obtained from Santa Cruz Biotech-
nology Inc. (USA). These were goat polyclonal 
antibodies specific for N-terminal domains of 
TLR1, TLR2, TLR3, TLR5 and TLR6, and a goat 
polyclonal antibody specific for the C-terminal 
domain of TLR4. Blocking peptides specific for 
the respective antibodies were used to detect 
non-specific staining.
Immunostaining
For immunostaining, OE-E6/E7 cells were 
cultured in four well chamber slides. They were 
cultured at 37˚C in Dulbecco’s Modified Eagle 
Medium- F12 ( DMEM-F12) culture medium (In-
vitrogen, UK) supplemented with 1% penicillin 
and streptomycin (Sigma-Aldrich, UK),  10% fe-
tal calf serum (FCS, Invitrogen, USA) and L-glu-
tamine (Invitrogen, USA) in 5% CO2 atmosphere. 
At confluency, the slides were washed five times 
with Ca2+ and Mg2+ free phosphate buffered saline 
(PBS, Gibco, USA), fixed with 5% formalin and 
stored at 4˚C until use.
Formalin-fixed slides were washed in PBS and 
then stained using a Vectastain Elite ABC per-
oxidase kit (Vector Laboratories Ltd, UK). In ad-
dition, to avoid non-specific binding, an avidin/
biotin blocking kit (Vector) was used. Briefly, 
slides were blocked for 1 hour at room tempera-
ture in PBS solution containing 0.2% v/v horse 
serum and 25% v/v avidin supplied in the block-
ing kit. The block was subsequently removed 
and slides were incubated for 2 hours at room 
temperature with primary antibody at an appro-
priate dilution using antibody diluent media (Da-
kocytomation Ltd, UK) and 250 ml biotin per ml 
of diluted antibody. Binding was then visualized 
by incubating the slide with peroxidase substrate 
3-amino-9-ethylcarbazole (AEC) (Vector) for 10 
minutes, washed in distilled water for 3 minutes 
and counterstained in 10% haematoxylin for 10 
minutes. Slides were finally washed in tap wa-
ter for 2 minutes and mounted with Aquamount 
(VWR International, UK).
Optimal staining was achieved by incubating 
slides with different concentrations of TLR anti-
bodies (TLR1, TLR2, TLR3, TLR4, TLR5, TLR6 
with 4, 4, 10, 10, 4 and 10 µg/ml respectively). 
Negative control sections were obtained by block-
ing the primary antibody with the corresponding 
specific peptide. Immunostained sections were 
examined using an Olympus BH2 microscope 
(Olympus, UK). 
Toll like receptors expression in OE-E6/E7 cells
TLR expression in the OE-E6/E7 cell line was 
investigated and compared to fallopian tube tissue 
samples. OE-E6/E7 cells were cultured at 37˚C in 
DMEM (F12) supplemented with 1% penicillin 
and streptomycin, 10% FCS and L-glutamine in 
5% CO2 atmosphere. At confluency, cells were 
washed with Ca2+ and Mg2+ free PBS and then har-
vested using trypsin-Ethylenediaminetetraacetic 
acid (EDTA, Invitrogen, USA) pelleted by cen-
trifugation at 300 g for 5 minutes. One ml of TRI-
reagent (Sigma, UK) was added onto the pellet 
(5×106 cells). Thereafter, total RNA from pelleted 
cells was extracted following the standard protocol 
supplied by the manufacturer.
 On the day of the experiment, fallopian tube tis-
sues were removed from RNAlater and homoge-
nised in 3 ml of TRI reagent using an Ultra-Turrax 
homogenizer for 2 minutes following the standard 
protocol supplied by the manufacturer. 
Total RNA obtained from OE-E6/E7 cells and 
fallopian tube tissue samples (by using chloroform 
and isopropanol) were then treated with DNase I 
(DNA-freeTM, Ambion, USA) to remove genomic 
DNA contamination from the samples. First strand 
cDNA was synthesized by reverse transcription 
using oligodT primers (Metabion, Germany) and 
SuperScript II (200 U/µl, Invitrogen, USA). RT 
controls were prepared without the enzyme (non-
reverse-transcribed controls). 
Polymerase chain reaction (PCR) was per-
formed using prepared cDNA, Platinum Blue 
PCR Super Mix (Invitrogen, USA) and prim-
ers from Metabion (Table 1). The amplification 
was run for 40 cycles under the following con-
ditions: initial heat at 95˚C for 30 secends, 59˚C 
to 65˚C for 30 seconds and final annealing at 
72˚C for 30 seconds. All experiments included 
reverse transciptase (RT) controls as well as 
negative controls (no cDNA). PCR products 
were visualised on a 1.2 % agarose gel. All am-
plified PCR products were sequenced to con-
firm the identity of the amplified product.
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Table 1: Sequence of primers used in this study
RefrenceProduct size 
(bp)
Accession no.Annealing
temperatue (C)
Primer  (5ˊ-3ˊ) Genes
43250Gene Bank:63F: GGGTCAGCTGGACTTCAGATLR1
U88540.1R: AAAATCCAAATGCAGGAACG
43175Gene Bank:60F: TCGGAGTTCTCCCAGTTCTCTTLR2
NM_003264.3R: TCCAGTGCTTCAACCCACAA
43156Gene Bank:60F: GTATTGCCTGGTTTGTTAATTGGTLR3
NM_003265.2R: AAGAGTTCAAAGGGGGCACT
3298Gene Bank:60F: TGATGTCTGCCTCGCGCCTGTLR4
NM-138554.3R: AACCACCTCCACGCAGGGCT
43111Gene Bank:60F: CACCAAACCAGGGATGCTATTLR5
NM_003268.5R: CCTGTGTATTGATGGGCAAA
43101Gene Bank:60F: GCCACCATGCTGGTGTTGGCTTLR6
NM-006068.4R: CGCCGAGTCTGGGTCCACTG
43285Gene Bank:63F: CCTTGAGGCCAACAACATCTTLR7
NM_016562.3R: GTAGGGACGGCTGTGACATT
4390Gene Bank:60F: CTTCGATACCTAAACCTCTCTAGCACTLR8
NM_138636.4R: AAGATCCAGCACCTTCAGATGA
43207Gene Bank:60F: TTCCCTGTAGCTGCTGTCCTLR9
NM_017442.3R: ACAGCCAGTTGCAGTTCACC
43184Gene Bank:60F: TGCCCACCACAATCTCTTCCATGATLR10
NM-030956.3R: AGCAGCTCGAAGGTTTGCCCA
4390Gene Bank:60F: CAAGATCATTGCTCCTCCTGβ-actin
NM-001101R: ATCCACATCTGCTGGAAGG
43122Gene Bank:60F: CTCATTTCCTGGTATGACAACGAGAPDH
NM_002046.4R: CTTCCTCTTGTGCTCTTGCT
TLR; Toll like receptor.
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Cell culture in the presence of sex hormones
To investigate the effect of estradiol and pro-
gesterone on TLR expression in the OE-E6/E7 
cell line, OE-E6/E7 cells were cultured again in 
triplicates at 37˚C in DMEM (F12) culture medi -
um and water soluble estradiol and progesterone 
(Sigma-Aldrich, UK) to reach the final concentra-
tions of 0.1, 1, 10, 100  nM and 1, 10, 100, 1000 
nM for estradiol and progesterone respectively. In 
addition, the following combinations of these two 
(final concentrations) were used in four groups of: 
control (C, without any additional treatment of sex 
hormones), menstruation (M, 1 nM progesterone 
and 0.1 nM estradiol), pre-ovulation (P, 6.5 nM 
progesterone and 1.5 nM estradiol) and window of 
implantation (W, 35 nM progesterone and 1 nM 
estradiol) in 5% CO2 atmosphere in 75 ml flasks 
for 24 hours in the absence of phenol red and se-
rum. In the next step, the effect of sex hormone an-
tagonists on TLR expression was evaluated. To do 
this, OE-E6/E7 cells were divided in two groups. 
One group was pre-treated for 2 hours with 1 µM 
ICI 182, 780 (fulvestrant, an estradiol antagonist, 
Sigma-Aldrich, UK) and the other pre-treated for 2 
hours with 0.1 µM RU486 (mifepristone, a proges-
terone antagonist, Tocris, USA). After pre-treat-
ment, both groups were treated again separately 
with a combination of estradiol and progesterone 
based on the four treatment groups (C, M, P and 
W) in 5% CO2 atmosphere in 75 ml flasks for 24 
hours in the absence of phenol red and serum. 
Cells were next treated for RNA isolation and 
cDNA synthesis following the same protocol men-
tioned above. qRT-PCR was performed using the 
cDNA prepared from the estradiol and progester-
one treatment experiments, same primers as in ta-
ble 1 and SYBR Green Jump Start (Sigma, UK) 
master mix (containing 10 µl SYBR Green, 7 µl 
Water, 1 µl of each primer and 1 µl cDNA). The 
PCR amplification was performed under the fol-
lowing conditions: 50 cycles of 95˚C for 30 seci-
onds, 59˚C to 63˚C for 30 seconds and 72˚C for 
30 seconds. All experiments included RT controls 
and negative controls (no cDNA). qRT-PCR was 
performed on a Mx3005P QPCR machine (Strata-
gene, Germany) and results were analyzed using 
MxPro QPCR software version 4.01. In prelimi-
nary experiments, the efficiency of the primer sets 
of each Q-PCR reaction was established. Varia-
tion in Beta-actin and GAPDH expression as two 
housekeeping genes was also tested.
The qRT-PCR data were analyzed using the 
comparative CT method (51). The fold change was 
calculated as FC=2-∆∆CT. 
The results were expressed as mean ± SEM. Sig-
nificance testing was performed by one-way ANO-
VA with Tukey’s multiple comparison test. P<0.05 
was considered significant.
Results
Reverse transcriptase-polymerase chain reaction 
Figure 1 shows the results of RT-PCR of TLR1-
10 genes in the human fallopian tube tissue. Figure 
2 shows the results of RT-PCR of TLR1-6 genes in 
OE-E6/E7 cells. Size of all amplified PCR prod-
ucts were as predicted and sequencing verified 
correct amplification of each gene. No product was 
amplified in negative control samples, indicating 
absence of genomic DNA contamination.
Immunostaining
Formalin-fixed slides were used to study the distri-
bution of TLR1-6 in OE-E6/E7 cells. Positive immu-
nostaining for all six TLRs was observed with TLR1, 
2, 4 and TLR6 displaying moderate staining in this 
epithelial cell line. However, strong staining for TLR3 
and TLR5 was observed. The immunocytochemical 
localisation of TLR1-6 is shown in figure 3. 
Quantitative polymerase chain reaction
A stable expression of Human ß-actin and GAPDH 
genes with variable hormonal treatments was ob-
served (Fig.4).The quantitative expression profiles of 
TLR1-6 genes in OE-E6/E7 cells treated with vary-
ing concentrations of estradiol and progesterone are 
shown in figures 5 and 6 respectively. The relative ex-
pression of TLR1-6 genes did not significantly differ 
in response to different concentrations of either estra-
diol or progesterone. The mean relative expression of 
TLR1-6 differed considerably between P, M, W and 
C groups (Fig.7). The Pattern of TLR expression in 
P, M and W were significantly different among P, M 
and W groups. Also, by using 1 µM of fulvestrant 
(estradiol antagonist) or 0.1 µM mifepristone (pro-
gesterone antagonist) 2 hours prior to the combined 
estradiol and progesterone treatment, the mean rela-
tive expression of TLR1-6 did not differ markedly in 
C, P, M and W groups (Figs.8, 9). 
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Fig.1: The expression of TLR1-10 genes in the human fallopian tube tissue. Each pair of primers produced a specific product with the spe-
cific predicted size observed in the test (T) samples. C; Control samples (samples without using cDNA) and TLR; Toll like receptor.
Fig.2: The expression of TLR1-6 genes in the human fallopian tube cell line (OE-E6/E7). Each pair of primers produced a specific product with 
the specific predicted size observed in the test (T) samples. C; Control samples (samples without using cDNA) and TLR; Toll like receptor.
Fig.3: Immunohistochemical staining of TLR1-6 in the OE-E6/E7 cell line. Positive staining is red, negative staining is blue. Small inserts 
show blocking of anti TLR1-6 antibodies with respective specific peptides. TLR; Toll like receptor.
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Fig.4: The stable expression of GAPDH and β-actin in OE-E6/E7 under variable hormonal treatments. E; Estradiol, P; Progestrone, C; Con-
trol, M; Menstruation and W; Window of implantation.
Fig.5: Expression of TLR1-6 in OE-E6/E7cultured with estradiol. Mean ± SEM of normalized expression values (with β-actin) for TLR1-6 
genes in OE-E6/E7 cultured with different concentrations of estradiol (control: 0 nM, E 0.1: 0.1 nM, E1: 1 nM, E10: 10 nM and E100: 100 
nM or 1 µM). No significant results were obtained. TLR; Toll like receptor.
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Fig.6: Expression of TLR1-6 in OE-E6/E7cultured with progesterone. Mean ± SEM of normalized expression values (with β-actin)  for TLR1-
6 genes in OE-E6/E7 cultured with different concentrations of progesterone (control: 0 nM, P1: 1 nM, P10: 10 nM, P100: 100 nM and 
P1000: 1000 nM or 1 µM). No significant results were obtained. TLR; Toll like receptor.
Fig.7: Expression of TLR1-6 in OE-E6/E7 cultured with a combination of estradiol and progesterone concentrations. Mean ± SEM 
of normalized expression values (with β-actin) for TLR1-6 genes in OE-E6/E7 cultured with a combination of estradiol and progesterone. 
Control (C, without any additional treatment of sex hormone), menstruation (M, 1 nM progesterone and 0.1 nM estradiol), pre-ovulation 
(P, 6.5 nM progesterone and1.5 nM estradiol) and window of implantation (W, 35 nMprogesterone and 1 nM estradiol) (control: 0 nM, P1: 
1 nM, P10: 10 nM, P100: 100 nM and P1000: 1000 nM or 1 µM). Star denotes statistically significant differences. TLR; Toll like receptor.
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Fig.8: Expression of TLR1-6 in OE-E6/E7 precultured with fulvestrant, then cultured with a combination of estradiol and progesterone 
concentrations.  Mean ± SEM of normalized expression values (with β-actin)  for TLR1-6 genes in OE-E6/E7 pre-cultured with fulvestrant 
for 2 hours, then cultured with a combination of estradiol and progesterone in 4 groups (C, M, P, W). No significant results were obtained. 
TLR; Toll like receptor.
Fig.9: Expression of TLR1-6 in OE-E6/E7 pre-cultured with mifepristone and cultured with a combination of estradiol and progesterone in 
4 groups (C, M, P, W).  Mean ± SEM of normalized expression values (with β-actin) for TLR1-6 genes. No significant results were obtained. 
TLR; Toll like receptor.
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Discussion
Epithelial cells are the first layer of defense 
against pathogens ascending FRT. Considering 
their role in protecting the tract from the external 
environment, TLRs are expected to be present in 
this tissue. Several studies have investigated the 
presence and the role of TLRs in FRT especially 
within the fallopian tube (34-42, 52). Previously, 
Pioli et al. (39), showed the presence of TLR1-6 in 
the FRT as well as the accessory molecule CD14 
and the molecular adapter MyD88 both of which 
are needed for TLR signalling. They also observed 
expression of TLR1-6 at the transcript level in fal-
lopian tubes. In agreement with this report, we pre-
viously showed the localization of TLR1-6 in the 
fallopian tube using immunohistochemistry (36). 
Both observations are in agreement with our find-
ings in this study that demonstrate the presence of 
TLR1-6 transcripts in human fallopian tube tissues 
and cell line. The expression of TLR4 protein and 
transcript has been detected in human endometrial 
epithelial cells, stromal cells (38) and fallopian 
tube stromal fibroblasts (53). However, TLR4 ex-
pression was not detected in fallopian tube epithe-
lial cells by Itoh et al. (53). In another study Hart et 
al. (42), reported the expression of TLR7–9 in the 
fallopian tube, uterine, endometrium, cervix and 
ectocervix, while TLR10 expression was restricted 
to the fallopian tube.
In this study, although expression of TLR1-10 
was detected in human fallopian tube tissues, ex-
pression of only TLR1-6 was detected in OE-E6/
E7 cells. This may be due to difference in features 
of the fallopian tube tissue and this specific cell 
line. Fallopian tube tissue contains an epithelial 
layer, stroma and capillaries supplying blood. 
Within the epithelial layer of the fallopian tube tis-
sue, some of the cells are ciliated and some are 
known as secretory cells. The OE-E6/E7 cell line 
is only an isolated fallopian tube epithelial layer 
cell line. Therefore, the expression of TLR genes 
and their level of expression in this cell line is like-
ly to be different compared with the original tissue 
consisting of different types of cells. The other po-
tential explanation for the absence of expression of 
some TLRs in OE-E6/E7 cells may be due to dif-
ferences between immortalised cell lines and their 
original parental primary cells. It is known that 
cell lines may undergo changes due to the process 
of immortalization. However, the characteristics 
of this immortalized cell line have been compared 
to the parental human fallopian tube epithelium 
in several investigations. For example, human 
oviduct-specific glycoprotein, estradiol receptors 
and cytokeratin molecules have been found to be 
produced in both primary fallopian tube cells and 
OE-E6/E7 cells (50, 54, 55).
The FRT environment is under the control of 
sex hormones during the menstrual cycle. Sex 
hormones not only regulate anatomical and histo-
logical characteristics of this tract (56, 57), they 
are also involved in the influx and localization of 
immune cells in this tract (58-60). For example, 
uterine natural killer (uNK) cells are found in the 
human uterus in large numbers and are spread 
throughout the endometrium with increasing num-
bers as the menstrual cycle progresses (61, 62). In 
addition, the adaptive immune system is also in-
fluenced by the changing levels of sex hormones 
during the menstrual cycle. Antigen presentation 
has been shown to be suppressed in response to 
increasing concentrations of estradiol (63, 64). 
Sex hormones including estradiol and progester-
one tightly control the distribution of macrophages 
within the endometrium (65-68). Another study 
demonstrated that estradiol,  which is secreted by 
the ovary during the menstrual cycle, modulates 
epithelial cells and other immune cells in FRT di-
rectly and indirectly to regulate a wide range of 
immune functions specific to each site in FRT 
(69). Nasu and Narahara (49) also showed that 
antigen-presenting cells in the uterus and vagina 
are responsive to estradiol where antigen presenta-
tion as well as co-stimulatory molecule expression 
is inhibited by estradiol. Furthermore, they sug-
gested that antigen-presenting cells in the uterus 
and vagina respond to selected TLR agonists with 
altered antigen presentation.
It is therefore likely that the action of TLRs is 
also modified by changing concentrations of estra-
diol and progesterone. Although all TLR molecules 
are expressed throughout the cycle, the majority 
of these genes are expressed at their lowest level 
during menstrual and proliferative stages of the 
cycle (34). At follicular stage of the cycle, while 
progesterone levels are at their lowest, estradiol 
levels are at their highest. This may indicate an 
inhibitory effect of estradiol and/or enhancing in-
fluence of progesterone on the expression of TLR 
molecules in FRT, especially in the endometrium. 
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It is plausible that this alteration in TLR gene ex-
pression may even influence the function of TLRs 
in mediating innate immune responses in FRT. To 
test these hypotheses, we examined the effect of 
sex hormones on TLR expression in the OE-E6/
E7 cell line. We used various concentrations of es-
tradiol and progesterone to determine the effects 
of these sex hormones on TLR expression. No 
significant alteration in the relative expression of 
TLR1-6 transcripts was observed in the fallopian 
tube cell line in response to different concentra-
tions of estradiol and progesterone. These results 
agreed with the findings of Lesmeister et al. (47) 
who also showed that in vitro treatment of endo-
metrial epithelial cell line (RL95-2) with 17beta-
estradiol did not have an effect on TLR3 transcript 
or protein expression. Also, in a recent study on 
human uterine epithelial cells and the ECC-1 uter-
ine epithelial cell line, Nasu and Narahara (49) 
demonstrated that estradiol either alone or prior 
to treatment with poly (I:C), had no effect on the 
expression of interferon β (IFNβ) or interferon-
stimulated genes (ISG). However, another study 
showed that production and secretion of protec-
tive antimicrobials including human β defensin-2 
(HBD2) and secretory leukocyte protease inhibi-
tor (SLPI) are directly upregulated by estradiol. 
On the contrary, estradiol inhibited LPS and poly 
(I:C)- induced secretion of macrophage inhibitory 
factor (MIF), interleukin 6 (IL-6) and IL-8 in pri-
mary uterine epithelial cells (70).
In the next step of our study, combined effect 
of estradiol and progesterone was evaluated. Ex-
pression of TLR1-6 was higher when the level of 
sex hormones in culture media was comparable to 
their concentration in serum during the window 
of implantation (group W) in the menstrual cycle. 
These results agreed with our previous findings 
where higher expression of TLRs was observed 
during the secretory phase in human endometrium 
(34, 71). These findings demonstrated a stimula-
tory effect of co-presence of both sex hormones 
(M, P and W) on TLR1-6 expression.
A recent study reported the fluctuation of TLR 
responsiveness in peripheral blood throughout 
the menstrual cycle (72). In agreement with our 
data, during the follicular phase, lower levels of 
IL-6 and tumor necrosis factor (TNF)-α following 
stimulation with the TLR2 agonist, lower levels of 
IL-1β, IL-6 and TNF-α following stimulation with 
the TLR4 agonist LPS, and lower levels of IL-1β 
and TNF-α following stimulation of whole blood 
with the TLR5 agonist flagellin was observed 
when compared with the early luteal phase (72). 
Jorgenson et al. (46) also illustrated that TLR3 
transcript level in primary endometrial epithelial 
cells is menstural cycle-dependent. They showed 
TLR3 was expressed throughout the menstrual cy-
cle but at its highest during the secretory phase of 
the cycle. In another study, Yao et al. (73) reported 
that except TLR11, the expression of TLR1-10 is 
cycle-dependent in mouse. Whether the above 
mentioned findings are due to estradiol, progester-
one or their combined effect on FRT epithelium 
remains to be deciphered.
When fulvestrant (estradiol antagonist) or mife-
pristone (progesterone antagonist) was used, the 
combined effect of estradiol and progesterone on 
TLR expression was inhibited. These data thus 
confirm our results that on the expression of TLR1-
6 is not affected by progesterone and estradiol in-
dividually TLR1-6 but TLR1-6 under the synergis-
tic/additive effect of the combination of estradiol 
and progesterone.
In performing this investigation, we took several 
precautionary measures. The effect of hormones in 
cell culture experiments was tested in the absence 
of phenol red and serum. Phenol red has estradi-
olic properties and serum may contain small mol-
ecules with estradiolic effects and if present, may 
hamper the results of experiments. 
In in vitro culture systems and particularly in the 
presence of blood or serum samples, progesterone 
degrades quickly (74). To avoid early degradation 
of hormones during our cell culture experiments, 
we used water soluble estradiol and progesterone 
(Cyclodextrin-encapsulated 17β-estradiol and 
progesterone) which are stable and tested for cell 
culture applications. These compounds have been 
used in several similar investigations (75-79). Fur-
thermore, our results clearly demonstrated that 
these compounds do not alter TLR gene expression 
in cultured cells.
It seems that the pattern of TLR expression under 
different concentrations of estradiol and progester-
one (mimicking those of the menstrual cycle) is 
similar to the pattern of TLR expression in endo-
metrial tissue during the menstrual cycle (34). On 
the other hand, higher expression of TLRs in the 
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proliferative phase compared with menstruation 
as well as their higher expression in the secretory 
phase than other phases show that safety in the hu-
man fallopian tube at the time of ovulation or early 
embryo development is a key factor.
 Future studies should be directed towards un-
derstanding the role of signalling pathways that 
enable estradiol and progesterone  to modulate the 
expression and function of TLRs in FRT.
Conclusion
This study firmly points to the involvement of 
sex hormones in modulation of TLR gene expres-
sion in human fallopian tube cells. Further experi-
ments should be undertaken to reveal the regu-
latory mechanism(s) and signalling pathway(s) 
responsible for the effect of sex hormones in mod-
ulating innate immunity in human FRT.    
Acknowledgments
This study was financially supported by Royan 
Institute. We wish to thank Dr Kai-Fai Lee for 
his kind courtesy (providing us with the OE-E6/
E7 cell line) and Miss Arghavan Janan for skillful 
technical assistance. The authors declare that they 
have no conflict of interest. 
References
1. McCormack WM. Pelvic inflammatory disease. N Engl J 
Med. 1994; 330(2): 115-119. 
2. Witkin SS. Immunological aspects of genital chlamydia 
infections. Best Pract Res Clin Obstet Gynaecol. 2002; 
16(6): 865-874. 
3. Cates W Jr. Priorities for sexually transmitted diseases in 
the late 1980s and beyond. Sex Transm Dis. 1986; 13(2): 
114-117. 
4. Piot P, Plummer FA, Mhalu FS, Lamboray JL, Chin J, 
Mann JM. AIDS: an international perspective. Science. 
1988; 239(4840): 573-579. 
5. Jiang J, Karimi O, Ouburg S, Champion CI, Khurana A, 
Liu G, et al. Interruption of CXCL13-CXCR5 axis increas-
es upper genital tract pathology and activation of NKT 
cells following chlamydial genital infection. PloS One. 
2012; 7(11): e47487.
6. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical 
proteins linking innate and acquired immunity. Nat Immu-
nol. 2001; 2(8): 675-680. 
7. Takeda K, Akira S. Toll-like receptors in innate immunity. 
Int Immunol. 2005; 17(1): 1-14. 
8. Janeway CA Jr, Medzhitov R. Innate immune recognition. 
Annu Rev Immunol. 2002; 20: 197-216. 
9. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev 
Immunol. 2003; 21: 335-376. 
10. Medzhitov R, Janeway C Jr. The Toll receptor family and 
microbial recognition. Trends Microbiol.  2000; 8(10): 452-
456. 
11. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschn-
ing CJ. Peptidoglycan- and lipoteichoic acid-induced cell 
activation is mediated by toll-like receptor 2. J Biol Chem. 
1999; 274(25): 17406-17409. 
12. Underhill DM, Ozinsky A, Smith KD, Aderem A. Toll-like 
receptor-2 mediates mycobacteria-induced proinflamma-
tory signaling in macrophages. Proc Natl Acad Sci USA. 
1999; 96(25): 14459-14463. 
13. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, 
Dong Z, et al. Cutting edge: role of Toll-like receptor 1 in 
mediating immune response to microbial lipoproteins. J 
Immunol. 2002; 169(1): 10-14. 
14. Nakao Y, Funami K, Kikkawa S, Taniguchi M, Nishiguchi 
M, Fukumori Y, et al. Surface-expressed TLR6 participates 
in the recognition of diacylated lipopeptide and peptidogly-
can in human cells. J Immunol. 2005; 174(3): 1566-1573. 
15. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith 
KD, Wilson CB, et al. The repertoire for pattern recogni-
tion of pathogens by the innate immune system is defined 
by cooperation between toll-like receptors. Proc Natl Acad 
Sci USA. 2000; 97(25): 13766-13771. 
16. Wetzler LM. The role of Toll-like receptor 2 in microbial 
disease and immunity. Vaccine. 2003; 21 Suppl 2: S55-60. 
17. Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, Kusu-
moto S, et al. Human MD-2 confers on mouse Toll-like re-
ceptor 4 species-specific lipopolysaccharide recognition. 
Int Immunol. 2001; 13(12): 1595-1599. 
18. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira 
S, et al. Essential role of MD-2 in LPS responsiveness and 
TLR4 distribution. Nat Immunol. 2002; 3(7): 667-672. 
19. Pasare C, Medzhitov R. Toll-like receptors: linking innate 
and adaptive immunity. Microbes Infect.  2004; 6(15): 
1382-1387. 
20. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Good-
lett DR, et al. The innate immune response to bacterial 
flagellin is mediated by Toll-like receptor 5. Nature. 2001; 
410(6832): 1099-1103. 
21. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Rec-
ognition of double-stranded RNA and activation of NF-
kappaB by Toll-like receptor 3. Nature. 2001; 413(6857): 
732-738. 
22. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. 
mRNA is an endogenous ligand for Toll-like receptor 3. J 
Biol Chem. 2004; 279(13): 12542-12550. 
23. Jurk M, Heil F, Vollmer J, Schetter C, Krieg AM, Wagner H, 
et al. Human TLR7 or TLR8 independently confer respon-
siveness to the antiviral compound R-848. Nat Immunol. 
2002; 3(6): 499. 
24. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo 
H, et al. A Toll-like receptor recognizes bacterial DNA. Na-
ture. 2000; 408(6813): 740-745. 
25. Flacher V, Bouschbacher M, Verronese E, Massacrier C, 
Sisirak V, Berthier-Vergnes O, et al. Human langerhans 
cells express a specific TLR profile and differentially re-
spond to viruses and gram-positive bacteria. J Immunol. 
2006; 177(11): 7959-7967. 
26. Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tan-
credi S, et al. Human TLR10 is a functional receptor, ex-
pressed by B cells and plasmacytoid dendritic cells, which 
activates gene transcription through MyD88. J Immunol. 
2005; 174(5): 2942-2950. 
27. Chuang T, Ulevitch RJ. Identification of hTLR10: a novel 
human Toll-like receptor preferentially expressed in im-
mune cells. Biochim Biophys Acta. 2001; 1518(1-2): 157-
161. 
28. Growe RG, Luster MI, Fail PA, Lippes J. Quinacrine-
induced occlusive fibrosis in the human fallopian tube is 
due to a unique inflammatory response and modification 
 CELL JOURNAL(Yakhteh), Vol 17, No 4, Winter 2016 690
Sex Hormones Alter TLRs Expression in Fallopian Tube
of repair mechanisms. J Reprod Immunol. 2013; 97(2): 
159-166.
29. Ghosh M, Schaefer TM, Fahey JV, Wright JA, Wira CR. 
Antiviral responses of human Fallopian tube epithelial 
cells to toll-like receptor 3 agonist poly(I:C). Fertil Steril. 
2008; 89(5 Suppl): 1497-1506.
30. Koga K, Aldo PB, Mor G. Toll-like receptors and pregnan-
cy: trophoblast as modulators of the immune response. J 
Obstet Gynaecol Res. 2009; 35(2): 191-202.
31. Amirchaghmaghi E, Taghavi SA, Shapouri F, Saeidi S, 
Rezaei A, Aflatoonian R. The role of Toll like receptors in 
pregnancy. Int J Fertil Steril. 2013; 7(3): 147-153.
32. Taghavi SA, Ashrafi M, Mehdizadeh M, Karimian L, 
Joghataie M, Aflatoonian R. Toll- like receptors expression 
in follicular cells of patients with poor ovarian response. Int 
J Fertil Steril. 2014; 8(2): 183-192.
33. Khan KN, Kitajima M, Fujishita A, Nakashima M, Masuza-
ki H. Toll-like receptor system and endometriosis. J Obstet 
Gynaecol Res. 2013; 39(8): 1281-1292.
34. Aflatoonian R, Tuckerman E, Elliott SL, Bruce C, Aflatoo-
nian A, Li TC, et al. Menstrual cycle-dependent changes 
of Toll-like receptors in endometrium. Hum Reprod. 2007; 
22(2): 586-593. 
35. Andersen JM, Al-Khairy D, Ingalls RR. Innate immunity at 
the mucosal surface: role of toll-like receptor 3 and toll-like 
receptor 9 in cervical epithelial cell responses to microbial 
pathogens. Biol Reprod. 2006; 74(5): 824-831. 
36. Fazeli A, Bruce C, Anumba DO. Characterization of Toll-
like receptors in the female reproductive tract in humans. 
Hum Reprod. 2005; 20(5): 1372-1378. 
37. Fichorova RN, Cronin AO, Lien E, Anderson DJ, Ingalls 
RR. Response to Neisseria gonorrhoeae by cervicovagi-
nal epithelial cells occurs in the absence of Toll-like re-
ceptor 4-mediated signaling. J Immunol. 2002; 168(5): 
2424-2432. 
38. Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada 
M, et al. Evidence for the presence of Toll-like receptor 
4 system in the human endometrium. J Clin Endocrinol 
Metab. 2005; 90(1): 548-556.
39. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, 
Guyre PM. Differential expression of Toll-like receptors 2 
and 4 in tissues of the human female reproductive tract. 
Infect Immun. 2004; 72(10): 5799-5806. 
40. Pivarcsi A, Nagy I, Koreck A, Kis K, Kenderessy-Szabo A, 
Szell M, et al. Microbial compounds induce the expression 
of pro-inflammatory cytokines, chemokines and human 
beta-defensin-2 in vaginal epithelial cells. Microbes Infect. 
2005; 7(9-10): 1117-1127. 
41. Schaefer TM, Fahey JV, Wright JA, Wira CR. Innate im-
munity in the human female reproductive tract: antiviral 
response of uterine epithelial cells to the TLR3 agonist 
poly(I:C). J Immunol. 2005; 174(2): 992-1002. 
42. Hart KM, Murphy AJ, Barrett KT, Wira CR, Guyre PM, Pioli 
PA. Functional expression of pattern recognition receptors 
in tissues of the human female reproductive tract. J Re-
prod Immunol. 2009; 80(1-2): 33-40. 
43. Saeidi S, Shapouri F, Amirchaghmaghi E, Hoseinifar H, 
Sabbaghian M, Sadighi Gilani MA, et al. Sperm protec-
tion in the male reproductive tract by Toll-like receptors. 
Andrologia. 2014; 46(7): 784-790.
44. Aboussahoud W, Aflatoonian R, Bruce C, Elliott S, Ward J, 
Newton S, et al. Expression and function of Toll-like recep-
tors in human endometrial epithelial cell lines. J Reprod 
Immunol. 2010; 84(1): 41-51.
45. Li HWR, Liao SB, Chiu PCN, Tam WW, Ho JC, Ng EH, 
et al. Expression of adrenomedullin in human oviduct, its 
regulation by the hormonal cycle and contact with sper-
matozoa, and its effect on ciliary beat frequency of the ovi-
ductal epithelium. J Clin Endocrinol Metab. 2010; 95(9): 
E18-E25.
46. Jorgenson RL, Young SL, Lesmeister MJ, Lyddon TD, 
Misfeldt ML. Human endometrial epithelial cells cyclically 
express Toll-like receptor 3 (TLR3) and exhibit TLR3-
dependent responses to dsRNA. Hum Immunol.  2005; 
66(5): 469-482. 
47. Lesmeister MJ, Jorgenson RL, Young SL, Misfeldt ML. 
17Beta-estradiol suppresses TLR3-induced cytokine and 
chemokine production in endometrial epithelial cells. Re-
prod Biol Endocrinol. 2005; 3: 74. 
48. Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in 
pathogen recognition. Int Immunol. 2009; 21(4): 317-337.
49. Nasu K, Narahara H. Pattern recognition via the Toll-like 
receptor system in the human female genital tract. Media-
tors Inflamm. 2010; 2010: 976024.
50. Lee YL, Lee KF, Xu JS, Wang YL, Tsao SW, Yeung WS. 
Establishment and characterization of an immortalized 
human oviductal cell line. Mol Reprod Dev. 2001; 59(4): 
400-409. 
51. Livak KJ, Schmittgen TD. Analysis of relative gene ex-
pression data using real-time quantitative PCR and the 
2(-delta delta C(T)) method. Methods. 2001; 25(4): 402-
408. 
52. Gregorczyk KP, Krzyzowska M. Innate immunity to infec-
tion in the lower female genital tract. Postepy Hig Med 
Dosw (Online). 2012; 67: 388-401.
53. Itoh H, Nasu K, Nishida M, Matsumoto H, Yuge A, Nara-
hara H. Human oviductal stromal fibroblasts, but not ovi-
ductal epithelial cells, express Toll-like receptor 4: the site-
specific mucosal immunity of the human fallopian tube 
against bacterial infection. Am J Reprod Immunol. 2006; 
56(2): 91-101. 
54. Watters TM, Kenny EF, ONeill LA. Structure, function and 
regulation of the Toll/IL-1 receptor adaptor proteins. Im-
munol Cell Biol. 2007; 85(6): 411-419.
55. Ling L, Lee YL, Lee KF, Tsao SW, Yeung WS, Kan FW. 
Expression of human oviductin in an immortalized human 
oviductal cell line. Fertil Steril. 2005; 84 Suppl 2: 1095-
1103. 
56. Beier HM, Beier-Hellwig K. Molecular and cellular aspects 
of endometrial receptivity. Hum Reprod Update.  1998; 
4(5): 448-458. 
57. Classen-Linke I, Alfer J, Hey S, Krusche CA, Kusche M, 
Beier HM. Marker molecules of human endometrial dif-
ferentiation can be hormonally regulated under in-vitro 
conditions as in-vivo. Hum Reprod Update. 1998; 4(5): 
539-549. 
58. von Rango U, Classen-Linke I, Kertschanska S, Kemp B, 
Beier HM. Effects of trophoblast invasion on the distribu-
tion of leukocytes in uterine and tubal implantation sites. 
Fertil Steril. 2001; 76(1): 116-124. 
59. Spornitz UM. The functional morphology of the human 
endometrium and decidua. Adv Anat Embryol Cell Biol. 
1992; 124: 1-99. 
60. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White 
HD, Rathbun W, et al. Unique CD8+ T cell-rich lymphoid 
aggregates in human uterine endometrium. J Leukoc Biol. 
1997; 61(4): 427-435. 
61. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, 
Guyre PM, et al. Flow cytometric analysis of leukocytes 
in the human female reproductive tract: comparison of fal-
lopian tube, uterus, cervix, and vagina. Am J Reprod Im-
munol. 1997; 38(5): 350-359. 
62. Hunt JS. Immunologically relevant cells in the uterus. Biol 
Reprod. 1994; 50(3): 461-466. 
63. Qiu F, Cui Z. CD4+ T helper cell response is required for 
memory in CD8+ T lymphocytes induced by a poly(I:C)-
CELL JOURNAL(Yakhteh), Vol 17, No 4, Winter 2016 691
Zandieh et al.
adjuvanted MHC I-restricted peptide epitope. J Immunoth-
er. 2007; 30(2): 180-189. 
64. Welters MJ, Bijker MS, van den Eeden SJ, Franken KL, 
Melief CJ, Offringa R, et al. Multiple CD4 and CD8 T-cell 
activation parameters predict vaccine efficacy in vivo 
mediated by individual DC-activating agonists. Vaccine. 
2007; 25(8): 1379-1389. 
65. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Si-
mon JC, Gallo RL. Hyaluronan fragments stimulate en-
dothelial recognition of injury through TLR4. J Biol Chem. 
2004; 279(17): 17079-17084.
66. Yu L, Wang L, Chen S. Endogenous Toll-like receptor li-
gands and their biological significance. J Cell Mol Med. 
2010; 14(11): 2592-2603.
67. Frantz S, Kelly RA, Bourcier T. Role of TLR-2 in the activa-
tion of nuclear factor kappaB by oxidative stress in cardiac 
myocytes. J Biol Chem. 2001; 276(7): 5197-5203.
68. Wan T, Zhou X, Chen G, An H, Chen T, Zhang W, et al. 
Novel heat shock protein Hsp70L1 activates dendritic 
cells and acts as a Th1 polarizing adjuvant. Blood. 2004; 
103(5): 1747-1754.
69. Laflamme J, Akoum A, Leclerc P. Induction of human 
sperm capacitation and protein tyrosine phosphorylation 
by endometrial cells and interleukin-6. Mol Hum Reprod. 
2005; 11(2): 141-150.
70. Rodriguez-Martinez H, Kvist U, Ernerudh J, Sanz L, Cal-
vete JJ. Seminal plasma proteins: what role do they play?. 
Am J Reprod Immunol. 2011; 66 Suppl 1:11-22.
71. Aflatoonian R, Fazeli A. Toll-like receptors in female repro-
ductive tract and their menstrual cycle dependent expres-
sion. J Reprod Immunol. 2008; 77(1): 7-13. 
72. Sioud M. Innate sensing of self and non-self RNAs by Toll-
like receptors. Trends Mol Med. 2006; 12(4): 167-176.
73. Yao XD, Fernandez S, Kelly MM, Kaushic C, Rosenthal 
KL. Expression of Toll-like receptors in murine vaginal epi-
thelium is affected by the estrous cycle and stromal cells. 
J Reprod Immunol. 2007; 75(2): 106-119. 
74. Vahdat F, Hurtgen JP, Whitmore HL, Seguin BE, Johnston 
SD. Decline in assayable progesterone in bovine plasma: 
effect of time, temperature, anticoagulant, and presence 
of blood cells. Am J Vet Res. 1981; 42(3): 521-522. 
75. Gresack JE, Frick KM. Effects of continuous and intermit-
tent estradiol treatments on memory in aging female mice. 
Brain Res.  2006; 1115(1): 135-147. 
76. Gresack JE, Frick KM. Post-training estradiol enhances 
spatial and object memory consolidation in female mice. 
Pharmacol Biochem Behav. 2006; 84(1): 112-119. 
77. Karagenc L, Lane M, Gardner DK. Oestradiol, cyclodex-
trin-encapsulated 17beta-oestradiol and the oestradiol 
solubilizer 2-hydroxypropyl-beta-cyclodextrin all impair 
preimplantation mouse embryo development. Reprod Bi-
omed Online. 2004; 9(3): 280-286. 
78. Koster F, Felberbaum R, Finas D, Wunsch K, Schulz C, 
Diedrich K, et al. Progesterone and estradiol enhance lipid 
mediated transfection of Sk-Br-3 mammalian cancer cells. 
Int J Mol Med. 2002; 9(6): 617-620. 
79. Rucker B, Pochmann D, Furstenau CR, Carneiro-Ramos 
MS, Battastini AM, Barreto-Chaves ML, et al. Effects of 
steroid hormones on synaptosomal ectonucleotidase ac-
tivities from hippocampus and cortex of adult female rats. 
Gen Comp Endocrinol. 2005; 140(2): 94-100.  
Reproduced with permission of the copyright owner. Further reproduction prohibited without
permission.
View publication stats
